SusmedTSE:4263 -2.73%69 Current Ratio is 34.97 as of Dec. 2025, which is 40% above its 10-year median of 24.98. GuruFocus rates TSE:4263 with a GF Score™ of 69/100 and a GF Value™ of 円974.33 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 678 Healthcare Providers & Services companies, Susmed ranks better than 99.26% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Susmed's current ratio for the quarter that ended in Dec. 2025 was 34.97.
Susmed has a current ratio of 34.97. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Susmed's Current Ratio or its related term are showing as below:
TSE:4263'
s Current Ratio Range Over the Past 10 Years
Min: 13.64 Med: 24.98 Max: 77.34
Current: 35.29
During the past 6 years, Susmed's highest Current Ratio was 77.34. The lowest was 13.64. And the median was 24.98.
TSE:4263's Current Ratio is ranked better than 99.26% of 678
companies
in the Healthcare Providers & Services industry
Industry Median: 1.48
vs TSE:4263: 35.29
Susmed (TSE:4263) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Susmed Current Ratio Related Terms
Susmed Current Ratio Historical Data
* Premium members only.
The historical data trend for Susmed's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4263 vs VEEV, BTSG, TEM: Current Ratio Comparison
For the Health Information Services subindustry, Susmed's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Susmed Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Susmed's Current Ratio distribution charts can be found below:
* The bar in red indicates where Susmed's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Susmed (TSE:4263) has a Current Ratio of 34.97 as of Dec. 2025. This is 40% above median its historical median of 24.98. Over the past decade, Susmed's Current Ratio has ranged from 13.64 to 77.34. According to the industry distribution chart, Susmed ranks #5 out of 678 companies in the Healthcare Providers & Services industry, placing it in the top 0.7%.
Is Susmed's Current Ratio too high?
Susmed's current Current Ratio of 34.97 is 40% above median its 10-year median of 24.98. Over the past 10 years, this metric has ranged from a low of 13.64 to a high of 77.34. The Healthcare Providers & Services industry median Current Ratio is 1.48. Susmed's value of 34.97 is 2262.8% above this industry median. Based on the distribution chart, Susmed ranks #5 out of 678 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Susmed has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Susmed's Current Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Susmed ranks #5 out of 678 companies for Current Ratio. This places Susmed in the top 1% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.48. Susmed's value of 34.97 is 2262.8% above this benchmark. Historically, Susmed's own Current Ratio has ranged from 13.64 to 77.34 over the past decade. While the company's 10-year median is 24.98 vs. the industry median of 1.48, Susmed has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.48, based on 678 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Susmed's current Current Ratio of 34.97 is 2262.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Susmed's current Current Ratio is 34.97, which is 40% above median its own 10-year median of 24.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Susmed stock overvalued right now?
Based on GuruFocus' analysis, Susmed (TSE:4263) is currently considered Modestly Undervalued. The stock's GF Value™ is 円974.33, compared to a current price of 円818.00 — trading 16% below its estimated fair value. The current Current Ratio is 34.97, which is 40% above median its 10-year median of 24.98 and 2262.8% above the Healthcare Providers & Services industry median of 1.48. Susmed's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Susmed (TSE:4263), the current Current Ratio is 34.97 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Susmed (TSE:4263) Overvalued in 2026?
Based on GuruFocus' analysis, Susmed stock appears to be undervalued.
The current stock price of 円818.00 is trading 16% below its estimated GF Value™ of 円974.33.
GuruFocus considers Susmed to be Modestly Undervalued.
Key valuation signals for TSE:4263:
Current Ratio: 34.97 (40% above median its 10-year median of 24.98)
GF Value™: 円974.33 vs. price of 円818.00 (16% below fair value)
Industry Position: 2262.8% above the Healthcare Providers & Services median (#5 of 678)
No single metric tells the full story. See the TSE:4263 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Susmed Inc is engaged in the development of therapeutic smartphone apps and digital solutions to streamline clinical trials. It is currently developing therapeutic apps for patients with insomnia, breast cancer, kidney disease, and other conditions. In addition, it has developed Susumed System, which uses a proprietary blockchain technology to ensure the reliability of clinical trial data, and can reduce the manpower and costs allocated to clinical trials. The company's reportable segments are: the DTx Product Business, which derives maximum revenue, and consists of the development of therapeutic apps; and the DTx Platform Business, which provides general-purpose clinical trial systems and machine learning automated analysis systems.
69GF Score
Get the complete analysis for TSE:4263
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4263 has been successfully added to your 
